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Abstract
Background: Colon cancers are the frequent causes of cancer mortality worldwide. Recently bacterial toxins have received
marked attention as promising approaches in the treatment of colon cancer. Thermostable direct hemolysin (TDH) secreted
by Vibrio parahaemolyticus causes influx of extracellular calcium with the subsequent rise in intracellular calcium level in
intestinal epithelial cells and it is known that calcium has antiproliferative activity against colon cancer.
Key Results: In the present study it has been shown that TDH, a well-known traditional virulent factor inhibits proliferation
of human colon carcinoma cells through the involvement of CaSR in its mechanism. TDH treatment does not induce DNA
fragmentation, nor causes the release of lactate dehydrogenase. Therefore, apoptosis and cytotoxicity are not contributing
to the TDH-mediated reduction of proliferation rate, and hence the reduction appears to be caused by decrease in cell
proliferation. The elevation of E-cadherin, a cell adhesion molecule and suppression of b-catenin, a proto-oncogene have
been observed in presence of CaSR agonists whereas reverse effect has been seen in presence of CaSR antagonist as well as
si-RNA in TDH treated cells. TDH also triggers a significant reduction of Cyclin-D and cdk2, two important cell cycle
regulatory proteins along with an up regulation of cell cycle inhibitory protein p27
Kip1 in presence of CaSR agonists.
Conclusion: Therefore TDH can downregulate colonic carcinoma cell proliferation and involves CaSR in its mechanism of
action. The downregulation occurs mainly through the involvement of E-cadherin-b-catenin mediated pathway and the
inhibition of cell cycle regulators as well as upregulation of cell cycle inhibitors.
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Introduction
Colorectal cancer is the second leading cause of cancer and
cancer related mortality in the world [1]. It is the third most
common form of cancer and is most prevalent in industrialized
developed nations [1]. A number of reports suggest that the under
developed countries which are more susceptible to diarrhoeal
diseases, are less prone to colorectal cancer. An inverse
relationship has been observed between colorectal cancer and
enteric infections [2]. Currently several approaches have been
made to use bacteria or their products in the treatment of cancer
[3–5]. A significant suppression of subcutaneous tumours in mice
has been observed by combining anaerobic bacteria with several
chemotherapeutic agents [6]. More recently Azurin, a small
globular metalloprotein of Pseudomonas aeruginosa has been found to
be capable of inducing apoptosis in tumour cells by p53
stabilization, makes this protein suitable for being employed as
an anticancer agent [7,8]. Furthermore, Pitari et al. [9] have shown
that Escherichia coli heat stable enterotoxin (STa) suppress
proliferation of colon carcinoma cell (T84) by increasing
intracellular c-GMP. It has also been reported that heat stable
enterotoxin (STa) secreted by enterotoxigenic E. coli downregu-
lates human colon carcinoma cell (COLO-205) proliferation via
PKG-ERK44/42 mediated signaling [10]. In correlation with
these therefore, in the present study an attempt has been made to
evaluate the role of thermostable direct hemolysin (TDH), secreted
by V. parahaemolyticus and involved in gastrointestinal disorders
[11], in the regulation of colon carcinoma cell proliferation.
There are reports that TDH may induce diarrhoea by elevation
of the intracellular calcium through activation of calcium influx in
intestinal epithelial cells [12–14]. It is well known that calcium ion
(Ca
2+) is a universal secondary messenger and a key player in
many cellular signal transduction pathways [15,16]. Several
studies have shown that Ca
2+ plays a crucial role in prevention
of colon carcinogenesis [17,18]. Ca
2+ opposes tumorigenesis by
restricting proliferation through promotion of E-cadherin expres-
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20098sion and inhibition of b-catenin/Tcf-4 signaling [19,20]. It is also
known that high extracellular calcium promotes differentiation
and decreases the rate of cell proliferation in human intestinal
epithelial cells [21–23]. As TDH causes an increase in intracellular
calcium level in intestinal epithelial cells through activation of
calcium influx from extracellular environment and calcium-
sensing receptor plays a vital role in influx of extracellular
calcium, hence in this study we evaluate the potential of TDH in
the down-regulation of colonic carcinoma cell proliferation
(COLO 205). Our study reveals that TDH is capable of inducing
reduction of cell proliferation. It has been found that this effect
could be nullified by using CaSR si-RNA, indicating the
involvement of this molecule in the mechanism of action of the
toxin. Moreover, to understand the molecular mechanism of down
regulation of cell proliferation we have also analyzed the role of E-




Maintenance of cell culture and preparation of viable
cells
COLO-205 and HT-29 cell lines were purchased from NCCS,
Pune, India. The cells were routinely cultured in tissue culture
flasks and grown upto monolayers in RPMI-1640 and DMEM
medium (Gibco BRL, USA) respectively, supplemented with 10%
Fetal Bovine Serum (Gibco BRL, USA). Human fetal colonic
epithelial cell line (CRL-1831) procured from ATCC (Rockville,
MD) was maintained in DMEM:F-12 supplemented with 10%
fetal bovine serum (FBS), 25 mM HEPES (Sigma), 10 ng ml
21
cholera toxin (Sigma), 5 mgm l
21 insulin (Sigma), 5 mgm l
21
transferrin (Sigma) and 100 ng ml
21 hydrocortisone (Sigma).
The confluent monolayers were subcultured at the interval of 3–
4 days. The viability of the cells was routinely checked by trypan
blue (Gibco BRL, USA) exclusion. About 9065% cells were
remained viable.
TDH purification
TDH was purified to homogeneity from Vibrio parahaemolyticus
(strain number I-12366, serotype O3:K6) as described previously
[24].
si-RNA transfection
The expression of CaSR was blocked by transfection with si-
RNA (Santa Cruz Biotechnology, USA) by using the manufac-
turer’s protocol. The COLO-205 cells were transiently transfected
with CaSR si RNA for 24 h. The transfected cells were then used
for subsequent assays. For negative control experiments, scram-
bled si-RNA (Santa-Cruz Biotechnology, USA) was used.
RNA isolation, reverse transcriptase-polymerase chain
reaction and sequencing of calcium sensing receptor
(CaSR)
Total RNA was isolated from transfected and non-transfected
COLO-205 cells by using the manufacturer’s protocol (Ambion,
USA) and the concentrations were checked spectrophotometrically
(Bio-Rad, USA). Total RNA sample (2 mg) was reverse transcribed
into cDNA using Retro Script kit (Ambion, USA). The com-
plementary DNA served as template for the amplification of CaSR
and GAPDH by PCR in an automated thermal cycler (Eppen-
dorf). The primer sequences for CaSR (forward: 59-AATCTCG
AGATGGCATTTTATAGCTGC-39; reverse: 59-GCGGTAC-
CTTATGAATTCACTAC GTTTT-39), and GAPDH (forward:
59-GAAGGTGAAGGTCGGAGTC-39; reverse: 59-GAAGAT-
GGTGATGGGATTTC-39) were used for amplification. In case
of negative control no RT product was used. The purified PCR
product was subjected to sequence analysis by following the
modified dideoxy chain termination method (Applied Biosystems
model 3100 genetic analyzer automated sequencer).
Immunocytochemistry
The presence of CaSR in transfected and non-transfected
COLO-205 cells were observed by immunocytochemical method.
Briefly, the COLO-205 cells were grown separately on lysine
coated glass coverslips for 24 h. After incubation, the coverslips
were washed with Hank’s balanced salt solution (calcium free)
followed by fixation using 4% paraformaldehyde in PBS for
20 min. After washing, the cells were permeabilized with 0.2%
triton X-100 in PBS for 10–15 min with the subsequent
incubation in 1% BSA prepared in PBS for 1 h. The cells were
then washed and incubated with primary monoclonal antibody of
CaSR (1:100 dilution; ABR Affinity Bioreagents, USA) for 2 h
followed by the incubation with FITC-conjugated secondary
antibody (1:1000 dilution; Jackson Immunochemicals, USA) for
1 h in dark. Finally the cells were washed thoroughly and observed
under confocal microscope (Zeiss LSM 510).




21) cells were loaded with Fura-2AM
(5 mM) (Sigma, USA), a cell permeable calcium ion binding dye in
the dark at 37uC for 30 min in PBS-glucose (pH 7.2) (Gibco BRL,
USA) [25,26]. The COLO-205 cells loaded with Fura-2AM were
allowed to incubate in the absence (containing either 200 nM or
1 mM CaCl2) or presence of 10 mgm l
21 of TDH [27] at 37uC for
different time point in PBS-glucose containing 200 nM CaCl2,
1 mM CaCl2 (Sigma, USA), 1 mM GdCl3 (Sigma, USA), a potent
CaSR agonist with 200 nM CaCl2, 40 nM CaSR si-RNA (Santa
Cruz Biotechnology, USA) with 200 nM CaCl2 and 1 mM EGTA
(Sigma, USA), an extracellular calcium chelator for the each
separate experiment. After washing with PBS the cells were
analyzed with excitation at 340 nm and emission at 510 nm by
FACS-Calibur using CELLQUEST software (Becton Dickinson).
Cell proliferation assay
The extent of cell proliferation in presence of TDH was
determined by CyQuantH NF cell proliferation assay kit
(Molecular Probes, USA) by following the manufacturer’s
protocol. This is a non-radioactive assay based on the measure-
ment of cellular DNA content via fluorescent dye binding [28].
COLO-205 cells were seeded into 96-well opaque-walled plates at
a density of 1610
4 per well (100 ml) and they were allowed to
adhere for 6 h at 37uC. Then the cells were treated with either
media (containing either 200 nM or 1 mM CaCl2), protease
digested TDH in presence of 200 nM CaCl2 or TDH in presence
of 200 nM CaCl2, 1 mM CaCl2, 1 mM GdCl3 with 200 nM
CaCl2, 40 nM CaSR si-RNA with 200 nM CaCl2 and 10 mM
NPS-2390 with 200 nM CaCl2 (in separate sets) for 12 h. The cell
growth medium was then removed and 100 mlo f1 6 lysis/dye
binding solution was added into each well. The plate was
incubated at 37uC for 15 min, and the fluorescence intensity
was measured on a Microplate Reader (Bio-Rad) with a
wavelength of 485 nm for excitation and 530 nm for emission.
According to the calibration curve the fluorescence intensity is
directly proportional to the cell growth. Each assay was done in
triplicate and the mean results have been expressed as percent cell
growth.
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Lactate dehydrogenase activity was measured by using the LDH
Cytotoxicity Detection kit (Roche), according to the manufactur-
er’s instruction. COLO-205 cells were seeded at 5610
5 cells in 96-
well plates. Cells were then incubated in the absence or presence of
different concentrations of TDH for 12 h. After treatment, the cell
free supernatants were collected and then used in the LDH assay.
Apoptosis assay
Apoptosis was measured by the TUNEL (TdT-dUTP terminal
nick-end labelling) assay. Cells were plated in the 2-well glass slides
(Nunc). After 48 h of incubation with TDH (10 mg/ml), the
ApopTagH peroxidase kit (Millipore, USA) was used to detect in
situ apoptosis according to the manufacturer’s protocol. Briefly, cells
(approximately 5610
6 cells/ml) were fixed in paraformaldehyde, and
post-fixed in ice-cold ethanol/acetic acid (2:1 v/v). After applying the
equilibration buffer, the TdT (terminal deoxy-nucleotidyl transferase)
was added, followed by anti-dioxigenin conjugate. Slides were stained
with peroxidase substrate, counterstained by methyl green, dehy-
drated by xylene, and mounted under a glass coverslip to be viewed
under the microscope at 400 magnification.
Western blot analysis
COLO-205 cells were incubated without (in presence of either
200 nM or 1 mM CaCl2) or with 10 mgm l
21 of TDH for 1 h in
presence of 200 nM CaCl2, 1 mM CaCl2, 1 mM GdCl3 with
200 nM CaCl2, 40 nM CaSR si-RNA with 200 nM CaCl2 (in
separate sets). Treated and untreated COLO-205 whole cells were
washed with ice cold phosphate buffered saline containing 1 mM
Na3VO4, lysed in 50 ml of lysis buffer [20 mM Tris– HCl, pH- 8,
137 mM NaCl, 10% glycerol (v/v), 1% Triton X-100 (v/v), 1 mM
Na3VO4, 2 mM EDTA, 1 mM PMSF, 20 mM leupeptin and
0.15 units/ml aprotonin] for 20 min at 4uC. The lysates were
centrifuged at 15,000 g for 15 min and the supernatants
(containing Triton X-100 soluble proteins) were collected. Then
they were subjected to 10% SDS-PAGE and transferred to
nitrocellulose membrane and immunoblotted with monoclonal
antibodies of CaSR, b-Catenin, E-Cadherin, Kip1p27 and Cdk2
(Santa Cruz Biotechnology, USA), then incubated with alkaline
phosphatase conjugated secondary antibody (Jackson Immuno-
chemicals, USA). Actin was used as an internal control and
detected with anti-b-actin monoclonal antibody (Santa Cruz
Biotechnology, USA).
Densitometric analysis
Immuno reactive bands of each blot were photographed and
then images were digitized and analyzed by using Bio-Rad
Figure 1. SDS-PAGE and western blot analysis of Thermostable
Direct Hemolysin (TDH). (a) Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis showing the purification of the TDH of Vibrio
parahaemolyticus. Lane1- Protein molecular weight marker (Fermentus).
Lane2- Purified TDH (23 kDa). (b) Western blot analysis of purified
23 kDa TDH with anti-TDH antibody, produced by immunization of
mice with purified TDH of Vibrio parahaemolyticus.
doi:10.1371/journal.pone.0020098.g001
Figure 2. Expression of CaSR mRNA and presence of CaSR
protein in COLO- 205 cells. (a) RT-PCR product of amplified calcium
sensing receptor (CaSR) cDNA. Lane1- Amplified product of CaSR cDNA
(3253 bp) in si-RNA transfected COLO-205 cells. Lane2- DNA molecular
weight marker (Bangalore Genei). Lane3- Amplified product of CaSR
cDNA (3253 bp) in non-transfected COLO-205 cells. (b) Immunocyto-
chemical study showing the predominance of CaSR protein at the
plasma membrane in [i] si-RNA transfected COLO-205 cells and [ii] non-
transfected COLO-205 cells. The data shown are representative of three
independent experiments. (c) Immunoblot analysis of the expression of
CaSR in COLO-205. COLO-205 cell lysates were separated by SDS-PAGE,
transferred to the membrane and finally probed with monoclonal
antibody to CaSR. Lane 1, cells without CaSR si-RNA; Lane 2, cells in
presence of scramble si-RNA (as negative control); and Lane 3, cells with
CaSR si-RNA. b-Actin was used as loading control. The data shown are
representative of three independent experiments.
doi:10.1371/journal.pone.0020098.g002
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2+ level. Time dependent study of cytosolic free Ca
2+ rise in COLO-205 cells after treatment with 10 mg/
ml TDH. MFI, mean fluorescence intensities (arbitrary units) are measured by flow cytometry in the control (untreated) cells where 200 nM (m) and
1 mM [Ca
2+]o (#) is present and in TDH treated cells in presence of 200 nM [Ca
2+]o (D); 1 mM [Ca
2+]o (e); 1 mM GdCl3 and 200 nM [Ca
2+]o (%); 40 nM
CaSR si-RNA and 200 nM [Ca
2+]o (*); 1 mM EGTA (N). Data are obtained from four independent experiments.
doi:10.1371/journal.pone.0020098.g003
Figure 4. Effect of CaSR agonists and antagonists on TDH (10 mg/ml) induced downregulation of COLO-205 cell proliferation with
respect to control. TDH untreated cells (control) has been considered as 100% cell growth. Data represent the mean 6 SEM (n=3). The bars 1a, 2a,
3a, 4a, 5a, 6a and 7a represent the untreated (control) COLO-205 cells in each case in presence of 200 nM [Ca
2+]o (100% cell growth). The others bars
represent the TDH treated COLO-205 cells as follows, Bar 1b- TDH untreated in presence of 1 mM [Ca
2+]o (91.01% cell growth) Bar 2b- TDH treated in
presence of 200 nM [Ca
2+]o (64.28% cell growth). Bar 3b- TDH treated in the presence of 1 mM [Ca
2+]o (36.67% cell growth). Bar 4b- TDH treated in
the presence of 1 mM GdCl3 and 200 nM [Ca
2+]o (38.24% cell growth). Bar 5b- TDH treated in the presence of 40 nM CaSR si-RNA and 200 nM [Ca
2+]o
(87.05% cell growth). Bar 6b- TDH treated in the presence of 10 mM NPS-2390 and 200 nM [Ca
2+]o (83.29% cell growth). Bar 7b- Protease digested
TDH with 200 nM [Ca
2+]o(95.78% cell growth) The data represent mean 6 S.E.M. of three independent experiments, p,0.05.
doi:10.1371/journal.pone.0020098.g004
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immunoreactive bands were quantitated and expressed as the
ratio of each band density to the internal control (b-actin) band
density.
Statistical Analysis
The statistical significance was analyzed by Student’s t-test (two-
tailed) using SPSS 7.5 software. The results were expressed as the
mean 6 standard error of the mean (S.E.M.) where applicable, of
three independent experiments. Statistical significance was
assumed at p,0.01.
Results
Thermostable Direct Hemolysin (TDH)
After purification the protein was subjected to a 10% SDS-
PAGE and a single band of molecular weight 23 kDa was
obtained (Figure 1a), suggesting that the molecular weight of the
monomeric TDH is 23 kDa. The subsequent western blot analysis
also confirmed the 23 kDa size of purified TDH (Figure 1b).
Expression of CaSR mRNA and presence of CaSR protein
in COLO- 205 cells
In order to confirm the expression of CaSR mRNA, RT-PCR
was performed on transfected and non-transfected COLO-205
cells. Our data demonstrated that the expression of full-length
cDNA of CaSR (3253 bp) was noticeably reduced in transfected
cells compared to that of non-transfected one but the expression
levels of GAPDH gene remained same in both (Figure 2a). The
identity of the PCR product was confirmed by nucleotide
sequencing using an automated sequencer, which showed 96%
Figure 5. Lactate dehydrogenase (LDH) assay. A: Lactate dehydrogenase (LDH) release into the medium from COLO-205 cells incubated in
presence TDH. COLO-205 cells were incubated without or with different concentration of TDH for 12 h. Cell free supernatants were collected and
assayed. Data represent mean 6 S.E.M. of three independent experiments, p,0.05. B: Percent cytotoxicity (LDH release) measurements in colonic
carcinoma (COLO-205) cells (&) and normal human fetal colonic epithelial cells (%). Data represent the mean 6 SEM (n=3), p,0.05.
doi:10.1371/journal.pone.0020098.g005
Figure 6. Quantitation of the TUNEL assay in TDH treated
COLO-205 cells. The data are the mean values of five digitized images
from three independent experiments.
doi:10.1371/journal.pone.0020098.g006
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Accession No. D50855) (data not shown). The CaSR protein
expression was further confirmed by immunocytochemistry and
immunoblotting. The immunocytochemistry analysis showed
the major localization of the protein at the plasma membrane in
non-transfected cells (Figure 2b [ii]). In transfected cells very less
expression was found (Figure 2b [i]). To further confirm the
presence of CaSR in COLO-205 cells, immunoblotting was
performed and it was observed that both the non-transfected
and scrambled siRNA transfected cells illustrated the expression
CaSR, while the expression of CaSR was found to be
completely abolished in CaSR siRNA transfected cells
(Figure 2C).
Change of cytosolic free Ca
2+ level
Experiments using different doses of purified TDH on the rise of
[Ca
2+]i revealed that the maximum effect was achieved with
10 mgm l
21 of TDH concentration (data not shown). So, the
subsequent studies were done by using this concentration. Time-
dependent assay of intracellular calcium rise was done with
purified TDH in COLO-205 cells using Fura-2AM, a cell
permeable calcium ion binding fluorescence dye. It was observed
that TDH causes a time-dependent rise of intracellular calcium
[Ca
2+]i in the presence of 1 mM extracellular calcium [Ca
2+]o and
the maximum effect was found after 20 min of incubation
compared to control (MFI value 1.89 vs. 20.78, p,0.01, n=3)
(Figure 3). Chelation of [Ca
2+]o by EGTA inhibited the rise of
[Ca
2+]i by TDH from MFI value 14.36 to 2.89 (p,0.01, n=3)
(Figure 3) suggesting that TDH-mediated [Ca
2+]i rise is due to the
influx of calcium ion from extracellular environment. To evaluate
the involvement of calcium sensing receptor in TDH-mediated
calcium influx, we used 1 mM GdCl3, a potent CaSR agonist [29]
in the extracellular medium in presence of 200 nM [Ca
2+]o and
observed the rise of [Ca
2+]i which also reached to its maximum
level at 20 min of incubation with TDH with respect to control
(MFI value 1.89 vs. 17.33, p,0.01, n=3) (Figure 3). It was
observed that the TDH-mediated increase of [Ca
2+]i levels can be
prevented by transfecting COLO-205 cells with CaSR si-RNA
Figure 7. Role of TDH on E-cadherin expression in presence of CaSR agonist and antagonist in COLO-205 cells by Western Blot
analysis. (a) Representative western blot analysis of E-cadherin expression. Data represent mean 6 S.E.M. of three independent experiments,
p,0.05. (b) Densitometric analysis of immunoreactive bands of E-cadherin of COLO-205 cell. After western blot, immunoreactive bands are
photographed and then images are digitized and analyzed. Immunoreactive bands are quantitated and expressed as the ratio of each band density
to the internal control (b-actin) band density. Bar 1- TDH untreated in presence of 200 nM [Ca
2+]o and 40 nM CaSR siRNA. Bar 2- TDH treated in
presence of 200 nM [Ca
2+]o and 40 nM CaSR siRNA. Bar 3- TDH untreated in presence of 200 nM [Ca
2+]o. Bar 4- TDH untreated in the presence of
1 mM [Ca
2+]o. Bar 5- TDH treated in the presence of 1 mM GdCl3 and 200 nM [Ca
2+]o. Bar 6- TDH treated in presence of 1 mM [Ca
2+]o. Bar 7- TDH
treated in the presence of 200 nM [Ca
2+]o.
doi:10.1371/journal.pone.0020098.g007
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negative control experiment the effect of scrambled si-RNA was
not observed (data not shown). These data indicated that CaSR
may be involved in the mechanism of intracellular calcium rise by
TDH.
Effect of TDH and CaSR in the regulation of cell
proliferation
To observe the involvement of CaSR in TDH mediated
downregulation of cell proliferation, the COLO-205 cells were
incubated with TDH in presence of 200 nM [Ca
2+]o and 64.28%
of cell growth was observed compared to that of untreated one,
contains only 200 nm [Ca
2+]o (which was considered as 100% of
cell growth) (Figure 4). Treatment with TDH in presence of 1 mM
[Ca
2+]o and GdCl3 in separate sets showed 36.67% and 38.24% of
cell growth respectively (Figure 4). However, incubation with
10 mM NPS-2390, a potent CaSR antagonist (Sigma, USA) [19] in
TDH-treated cells caused 83.29% cell growth. Transfection with
CaSR si-RNA decreased the cell growth to 87.05% (Figure 4)
whereas scrambled si-RNA reverted the phenomenon (data not
shown). These results suggested that TDH causes downregulation
of COLO-205 cell proliferation and CaSR may have a potent role
in this mechanism of action.
Lactase dehydrogenase and TUNEL assay
To determine whether the downregulation of cell proliferation
by TDH is due to cytotoxicity or apoptosis, lactase dehydrogenase
(LDH) and TUNEL assay were performed. At first we performed
a dose response study of TDH on COLO-205 cells with respect to
LDH release. We did not find cytotoxic activity of TDH till the
concentration of 12.5 mg/ml compared to untreated control. A
little cytotoxicity was observed at a very high concentration of the
toxin (62.5 mg/ml) (Figure 5a). Our results also revealed that the
CaSR agonists ([Ca
2+]o and GdCl3) and inhibitor (si-RNA) had no
significant effect on the release of LDH in TDH treated
(10 mgm l
21 for 12 h) COLO-205 cells and normal human fetal
colonic epithelial cells (Figure 5b). Moreover, it was examined that
TDH did not induce cell death as confirmed by TUNEL staining
(Figure 6).
Effect of TDH on expressions of E-cadherin and b-catenin
levels in COLO-205 cells
It has been reported earlier that E-cadherin (a well known
adhesion molecule) and b-catenin (a proto-oncogene) have potent
regulatory roles in cell proliferation [19]. To evaluate the
involvement of E-cadherin and b-catenin in the TDH mediated
downregulation mechanism of COLO-205 cell proliferation,
Figure 8. Role of TDH on b-catenin expression in presence of CaSR agonist and antagonist in COLO-205 cells by immunoblot
analysis. (a) Representative western blot analysis of b-catenin expression. Data represent mean 6 S.E.M. of three independent experiments, p,0.05.
(b) Densitometric analysis of immunoreactive bands of b-catenin of COLO-205 cell. After western blot, immunoreactive bands are photographed and
then images are digitized and analyzed. Immunoreactive bands are quantitated and expressed as the ratio of each band density to the internal
control (b-actin) band density. Bar 1- TDH treated in presence of 200 nM [Ca
2+]o. Bar 2- TDH treated in the presence of 1 mM [Ca
2+]o. Bar 3- TDH
treated in the presence of 1 mM GdCl3 and 200 nM [Ca
2+]o. Bar 4- TDH untreated in the presence of 1 mM [Ca
2+]o. Bar 5- TDH untreated in the
presence of 200 nM [Ca
2+]o. Bar 6- TDH treated in the presence of 40 nM CaSR si-RNA and 200 nM [Ca
2+]o.
doi:10.1371/journal.pone.0020098.g008
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Promotion of E-cadherin level occurred when the cells were
incubated with TDH in presence of 1 mM [Ca
2+]o and GdCl3 in
separate sets but the level decreased in presence of CaSR si-RNA
compared to that of the control (untreated) (Figure 7). Completely
reverse phenomenon was observed in case of b-catenin. Figure 8
showed that suppression of b-catenin level occurred in TDH-
treated cells as well as both in presence of 1 mM [Ca
2+]o and
GdCl3, but CaSR si-RNA reverted the effect of TDH in inhibition
of b-catenin expression level. These results suggest that TDH
downregulates cell proliferation through the CaSR-mediated
pathway by the upregulation of E-cadherin and reduction in b-
catenin levels.
Effect of TDH on the expressions of Cyclin D, cdk2 and
p27
Kip1 levels in COLO-205 cells
Cyclin D and cdk2 are two important regulatory molecules that
are associated with the G1-S phase transition of cell cycle and
expression of these two molecules are significantly correlated with
the degree of malignancy in a variety of human carcinomas [30–
33]. In this report, activity of Cyclin D and cdk2 were shown by
western blot analysis. It was observed that TDH treatment
inhibited Cyclin D level in COLO-205 cells. The degree of
inhibition increased further when the cells were treated with TDH
along with 1 mM [Ca
2+]o and GdCl3 but prior treatment with
CaSR si-RNA increased the Cyclin D level in TDH-treated cells
(Figure 9). Similar result was noticed in case of cdk2 expression
level also (Figure 10). It is well known that the cdk inhibitors
p21
Cip1 and p27
Kip1 play important roles in mediating growth
arrest and are thought to function as brakes of the cell cycle [34].
In the present study, immunoblot analysis with anti- p27
Kip1
antibody showed that the CaSR agonists [Ca
2+]o or GdCl3 raised
the p27
Kip1 level but inhibition of its expression occurred in TDH
treated CaSR si-RNA transfected cells (Figure 11), suggesting that
TDH causes downregulation of COLO-205 cell proliferation and
involve CaSR through the reduction of cell cycle regulatory




The ability of many live or attenuated pathogenic bacteria or
their components to cause cancer regression has been well known
for many years [3,4]. The most prominent example would be the
use of Mycobacterium bovis BCG, the vaccine strain, in the treatment
of bladder cancer [35]. The ability of Salmonella, Clostridia, and
other anaerobic bacteria to target tumors for their preferential
replication, leading to tumors regression has been reported by
Figure 9. Role of TDH on Cyclin D expression in presence of CaSR agonist and antagonist in COLO-205 cells by immunoblot
analysis. (a) Representative western blot analysis of Cyclin D expression. Data represent the mean 6 SEM (n=3). (b) Densitometric analysis of
immunoreactive bands of Cyclin D of COLO-205 cell. After western blot, immunoreactive bands are photographed and then images are digitized and
analyzed. Immunoreactive bands are quantitated and expressed as the ratio of each band density to the internal control (b-actin) band density. Bar 1-
TDH treated in the presence of 40 nM CaSR si-RNA and 200 nM [Ca
2+]o. Bar 2- TDH treated in presence of 200 nM [Ca
2+]o. Bar 3- TDH treated in the
presence of 1 mM GdCl3 and 200 nM [Ca
2+]o. Bar 4- TDH treated in the presence of 1 mM [Ca
2+]o. Bar 5- TDH untreated in the presence of 1 mM
[Ca
2+]o. Bar 6- TDH untreated in the presence of 200 nM [Ca
2+]o.
doi:10.1371/journal.pone.0020098.g009
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mitomycin C and the antivascular agent dolastatin-10 in
combination with the spores of an attenuated anaerobic
bacterium, Clostridium novyi, to treat colorectal cancer cells [36].
A couple of macrolides, epothilone A and epothilone B (EpoA and
EpoB) from the myxobacterium Sorangium cellulosum and particu-
larly a chemically modified synthetic form of EpoB, desoxy
epothilone B, have been shown to have antitumor activity against
a range of human tumors [37]. More recently, purified redox
proteins such as azurin have been shown to allow cancer
regression in nude mice harboring human melanoma [7]. It has
also been observed that bacterial enterotoxin suppress colon
carcinoma cell proliferation based on calcium dependent pathway
[9,10]. These studies inspired us to use thermostable direct
hemolysin (TDH), a well-known traditional virulence factor of V.
parahaemolyticus, in the regulation of colon carcinoma cell
proliferation (COLO-205). Vibrio parahaemolyticus, a marine bacte-
rium secretes thermostable direct hemolysin (TDH), which is
associated with diarrhoea [12]. It has been reported by Takahashi
et al., 2000 [27] that TDH involves calcium ions in its mechanism
of action and 10 mgm l
21 causes influx of [Ca
2+]o with the
subsequent rise of [Ca
2+]i in human intestine. It is also known that
the influx of [Ca
2+]o occurs through different receptors present on
the plasma membrane e.g. calcium sensing receptor (CaSR).
CaSR is activated not only by [Ca
2+]o but also by several
polyvalent cations e.g. GdCl3 and raises [Ca
2+]i level [29].
Moreover, extracellular calcium promotes differentiation and
decreases growth in the intestinal epithelial cells [38–40]. A report
suggests that activation of CaSR might be an important event in
the control of cell proliferation [41]. Therefore, in the present
work we have determined the role of CaSR in the mechanism of
action of TDH mediated downregulation of COLO-205 cell
proliferation.
Our study reveals that purified TDH raises intracellular calcium
concentration in presence of extracellular calcium and maximum
effect has been noticed after 20 min of incubation of cells in
presence of TDH. Chelation of extracellular calcium by EGTA
inhibits the rise in intracellular calcium level by TDH, which
corroborates the findings of Fabbri et al., 1999 [12] that TDH
raises intracellular calcium level through calcium influx from
extracellular environment. The rise of [Ca
2+]i in TDH-treated
cells has also been observed in presence of GdCl3, a potent CaSR
agonist [19]. However, no significant intracellular calcium rise has
been observed after transfecting COLO-205 cells with CaSR si-
RNA, suggesting that CaSR becomes activated both in presence of
calcium and gadolinium in TDH-treated COLO-205 cells and
increases [Ca
2+]i. Moreover, it has been found that TDH inhibits
cell proliferation in presence of extracellular calcium and
Figure 10. Role of TDH on cdk2 expression in presence of CaSR agonist and antagonist in COLO-205 cells by Immunoblotting. (a)
Representative western blot analysis of cdk2expression Data represent the mean 6 SEM (n=3). (b) Densitometric analysis of immunoreactive bands
of cdk2 of COLO-205 cell. After western blot, immunoreactive bands are photographed and then images are digitized and analyzed. Immunoreactive
bands are quantitated and expressed as the ratio of each band density to the internal control (b-actin) band density. Bar 1- TDH untreated in presence
of 200 nM [Ca
2+]o. Bar 2- TDH untreated in presence of 1 mM [Ca
2+]o. Bar 3-TDH treated in the presence of 200 nM [Ca
2+]o. Bar 4- TDH treated in the
presence of 1 mM GdCl3 and 200 mM [Ca
2+]o. Bar 5- TDH treated in presence of 1 mM [Ca
2+]o. Bar 6- TDH treated in the presence of 40 nM CaSR si-
RNA and 200 nM [Ca
2+]o.
doi:10.1371/journal.pone.0020098.g010
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effect of TDH with respect to TDH untreated (control) cells which
has been considered as 100% cell growth. Incomplete recovery of
cell growth to the control level in presence of CaSR inhibitors
suggests the possible existence of an alternative TDH-mediated
signaling pathway other than involvement of CaSR.
The reduction of cell proliferation rate can be explained either
by cell death or reduced proliferation. TUNEL assay and LDH-
release assay have been done to investigate whether treatment of
TDH causes apoptosis and cytotoxicity in COLO-205 cells.
Moreover, we are also interested to observe whether TDH has any
cytotoxic effect in normal colonic epithelial cells. A very few
TUNEL positive COLO-205 cells have been observed after TDH
treatment, whereas a significantly high number of positive cells
have been seen after treatment with curcumin as an apoptotic
inducer in positive control experiment. Furthermore, no signifi-
cant cytotoxicity has been found at a low concentration of TDH.
Significant cytotoxicity has been observed at a very high
concentration of the protein. These results correlate with the
previous finding of Hiyoshi et al., 2010 [42] and Raimondi et al.,
2000 [14], where cytotoxicity of TDH has been shown at a high
dose. Although the study of Raimondi et al. [14], demonstrates
that the high toxin dose exhibits calcium-independent cytotoxicity
in Caco-2 cells. Our present study reveals that the effect of TDH is
extracellular calcium dependent in COLO-205 cells. Moreover,
there is no statistically significant difference in LDH-release
between the control and TDH treated COLO-205 cells as well as
normal colonic epithelial cells both in presence of CaSR agonists
and inhibitor. The same experiments have been repeated in case
of HT-29, another colon carcinoma cell line and the results
obtained are similar like that of COLO-205 (data not shown). In
contrast to the observation made by Naim et al., 2001 [43] in rat-1
cells, our results suggest that apoptosis and cytotoxicity are not
contributing to the reduction of proliferation rate in colon
carcinoma cells and this reduction appears to be caused by
decrease in cell proliferation.
It has been reported earlier that E-cadherin and b-catenin have
potent regulatory role in colonic cell proliferation [19]. E-cadherin
plays a key role as a tumor suppressor in colon carcinoma cells,
and up-regulated expression of E-cadherin correlates with the
induction of differentiation [44]. We examined the expression of
E-cadherin by immunoblotting analysis. Our results reveal that
TDH in presence of 1 mM Ca
2+ and 1 mM Gd
3+ induces the
expression of E-cadherin, but the expression of E-cadherin has
Figure 11. Role of TDH on p27
Kip1 expression in presence of CaSR agonist and antagonist in COLO-205 cells by immunoblot
analysis. (a) Representative western blot analysis of p27
Kip1expression Data represent the mean 6 SEM (n=3). (b) Densitometric analysis of
immunoreactive bands of p27
Kip1 of COLO-205 cell. After western blot, immunoreactive bands are photographed and then images are digitized and
analyzed. Immunoreactive bands are quantitated and expressed as the ratio of each band density to the internal control (b-actin) band density. Bar 1-
TDH treated in the presence of 40 nM CaSR si-RNA and 200 nM [Ca
2+]o. Bar 2- TDH treated in presence of 200 nM [Ca
2+]o. Bar 3- TDH treated in the
presence of 1 mM GdCl3 and 200 nM [Ca
2+]o. Bar 4- TDH treated in the presence of 1 mM [Ca
2+]o. Bar 5- TDH untreated in the presence of 200 nM
[Ca
2+]o. Bar 6- TDH untreated in the presence of 1 mM [Ca
2+]o.
doi:10.1371/journal.pone.0020098.g011
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following TDH treatment. It is well known that E-cadherin
interacts with b-catenin, a component of the TCF/Wnt signaling
pathway, and activation of Wnt is involved with malignancy [45].
To evaluate the involvement of b-catenin on COLO-205 cell
proliferation, western blot analysis of b-catenin has been done.
The results demonstrate that TDH suppresses b-catenin level in
presence of [Ca
2+]o and GdCl3, whereas a reverse effect has been
observed in CaSR si-RNA transfected cells. This suggests the
involvement of CaSR in the downregulation of cell proliferation
by TDH.
Moreover, the expressions of Cyclin D and cdk2, two important
molecules associated with the G1-S phase transition of cell cycle
are also inhibited by TDH in [Ca
2+]o as well as GdCl3 treated
cells. Their expression levels are significantly correlated with the
degree of malignancy in a variety of human carcinomas [30–33].
It is well known that the cdk inhibitors e.g. p27
Kip1 play an
important role in mediating growth arrest and are thought to
function as brakes of the cell cycle [34]. In the present study
immunoblotting with anti- p27
Kip1 antibody suggests that TDH
raises the cdk inhibitory proteins and helps to pause the cell cycle
progression in presence of CaSR agonists but the level of p27
Kip1
decreases when CaSR is inhibited by its si-RNA. These results
indicate the possible involvement of CaSR in TDH mediated
downregulation of cell proliferation.
In conclusion, we have stated for the first time that thermostable
direct hemolysin can downregulate cell proliferation in COLO-
205 cells and involves calcium sensing receptor in its mechanism of
action. The downregulation occurs mainly through the involve-
ment of E-cadherin-b-catenin mediated pathway and the
inhibition of the cell cycle regulatory proteins e.g. Cyclin D,
cdk2 as well as upregulation of cdk inhibitor e.g. p27
Kip1 level.
This study clearly helps in developing our understanding that
TDH may be considered as a novel agent in the therapy of human
colorectal cancer in future.
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